combination chemotherapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (1)

Phase 3 (1)
Phase 4 (1)

Interventional (2)

Herui Yao (1)
IRCCS San Raffaele (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadepidermal growth factor

I am/have/haderbb2

I am/have/hadbreast cancer

I am/have/hadductal adenocarcinoma

I am/have/hadabsolute neutrophil count

I am/have/hadalopecia

I am/have/hadkidney function test

I am/have/hadmaintenance treatment

I am/have/hadimmunohistochemistry

I am/have/hadepidermal growth factor receptor

I am/have/hadblood test

I am/have/hadneutrophil count

I am/have/hadpancreatic adenocarcinoma

I am/have/hadcancer

I am/have/hadhair thinning

I am/have/hadHER2

I am/have/hadpancreatic ductal adenocarcinoma

I am/have/hadadenocarcinoma

I am/have/hadpdac

I am/have/hadadvanced breast cancer

added new label for I am/have/had

more

I am looking for

I am looking forepidermal growth factor

I am looking forgrowth factor

I am looking forerbb2

I am looking forcish

I am looking forchromogenic in situ hybridization

I am looking forcisplatin

I am looking forgemcitabine

I am looking forpaclitaxel

I am looking forhuman epidermal growth factor

I am looking forcapecitabine

I am looking forher-2

I am looking forfulvestrant

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Combination Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

This phase III trial aims to compare the progression free survival (PFS) and safety of fulvestrant or capecitabine as maintenance therapy after first-line combined chemotherapy in hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer.

epidermal growth factor

erbb2

cish

chromogenic in situ hybridization

breast cancer

0 views
19 Feb, 2024

Phase 4
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

PAXG Out in the Country

The objective of this study is to assess the reproducibility of PAXG regimen as first-line/primary chemotherapy in daily clinical practice in Pancreatic Ductal Adenocarcinoma (PDAC) borderline resectable, locally advanced or metastatic patients out of a large volume center.

neutrophil count

pdac

ductal adenocarcinoma

absolute neutrophil count

cisplatin

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.